{"schema_version":"secwatch.filing_event.v1","accession":"0000886163-25-000040","form_type":"8-K","ticker":"LGND","cik":"0000886163","company_name":"LIGAND PHARMACEUTICALS INC","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.623082+00:00","generated_at":"2026-05-19T17:51:44.865906+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Ligand shareholders re-elect all eight directors, ratify auditor, and approve say-on-pay","bullets":["All eight director nominees elected, with each receiving >15.5M votes for (excluding broker non-votes).","Ratification of Ernst & Young as independent auditor for FY2025 passed with 17.27M votes for.","Non-binding advisory vote on named executive officer compensation approved with 15.58M votes for.","Broker non-votes totaled 1.36M on director elections and say-on-pay; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0000886163-25-000040","json":"https://secwatch.observer/filing/0000886163-25-000040.json","markdown":"https://secwatch.observer/filing/0000886163-25-000040.md","text":"https://secwatch.observer/filing/0000886163-25-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886163/000088616325000040/0000886163-25-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886163/000088616325000040/lgnd-20250609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:51:44.865906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}